The 2012 CDC-sponsored study did not classify Morgellons as delusional infestation. It also did not identify a cause shared across the group. This audit follows the denominators and separates what the study measured from what later sources claimed.
morgellons disease
The Stain That Would Settle It
Research criticism · Dermatopathology · Morgellons
Reactive Perforating Collagenosis and Morgellons share plug and collagen observations but diverge on anatomy and symptoms. An intact, elastic-stained lesion could distinguish their tissue routes.
In reactive perforating collagenosis, damaged collagen can be pushed out through skin—and a pathologist can see that route under the microscope. Some Morgellons lesions are described as cratered or plug-centered. Middelveen has sectioned attached callus material and reported follicular casts and comedo-like masses. Those observations justify testing whether some lesions fit the RPC or acquired perforating dermatosis pattern. They do not already establish that diagnosis.
Can Morgellons Be Diagnosed as a Delusion? What a New Psychodermatology Review Gets Right—and Wrong
Research criticism • Psychodermatology • Source audit
A 2026 review correctly challenges reflexive psychiatric dismissal. Its own infectious claims, however, do not survive the same citation-level scrutiny.
LookExamine sensations, lesions, and fibers before interpreting them.
AttributeDistinguish a coexisting condition from a demonstrated cause.
VerifyFollow treatment and etiology claims back to their sources.
A patient can have real skin lesions, real fibers, real crawling sensations—and still face an unresolved question about what caused them. That is why disease versus delusion is the wrong binary.
CEHF’s “Morgellons Arthritis” Article Does Not Say What Its Sources Say
A closer reading of CEHF’s citations reveals a four-day mouse experiment described as months of joint swelling, an animal study blurred into a human PTLDS diagnosis, and a 6 percent figure whose denominator changes as it moves through the Morgellons literature.
On August 13, 2026, the Charles E. Holman Morgellons Disease Foundation published an official statement warning Morgellons patients about unnamed critics whom it accused of failing to engage properly with peer-reviewed literature and of “nitpicking” researchers. The Foundation urged patients to rely on credible sources and peer-reviewed information while presenting its own work as rooted in scientific integrity.
That is a reasonable standard, and it should apply equally to CEHF. A standing article on the Foundation’s website, Understanding Morgellons Arthritis (archived May 18, 2026), provides an unusually useful test because its claims are specific and its scientific citations can be traced back to the original studies. The article, bylined to Mark Wilcox, was published in December 2022 and last modified February 20, 2023.
Same Name, Different Patients: Why Morgellons Studies Keep Contradicting Each Other
Morgellons studies appear to reach opposite conclusions. The CDC-supported investigation identified ordinary environmental material and no common infectious cause. Filament-focused papers described biological structures associated with skin tissue and reported evidence of Borrelia. Psychiatric literature frequently classifies Morgellons as delusional infestation. These findings may conflict partly because the studies did not consistently examine the same patients, specimens or definition of Morgellons disease.
Every Morgellons investigation begins by deciding who qualifies as a case. That decision determines which patients enter the study, which materials are analyzed and what the results can reasonably establish. A population defined by self-reported fibers is not necessarily equivalent to one selected for filaments considered embedded in or projecting from tissue. A psychiatric referral population is different again.
This does not mean that every interpretation is equally supported. It means the evidence must be judged within the boundaries of each study. Until researchers establish reproducible diagnostic criteria and independent laboratories examine comparable specimens, the name “Morgellons” will continue to describe several overlapping—and potentially unrelated—clinical presentations.